NCT01535079

Acute Sore Throat Pain Study

Analgesic Profile of 3 New Ibuprofen Lozenges (V0498TA01A 15 mg, 25 mg, 35 mg) After Single Administration in Acute Sore Throat Pain

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 186 (actual)
• Sponsor: Pierre Fabre Medicament · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

"Sore throat is one of the most common complaints encountered in clinical practice. And in 65% of cases, the infection is thought to be viral in nature. The aim of this study is to evaluate the analgesic profile of 3 Ibuprofen lozenges after single administration in acute sore throat pain."

Conditions

• Acute Sore Throat Pain

Interventions

Type	Name	Description
DRUG	Placebo	Single administration
DRUG	Ibuprofen 35 mg	Single administration
DRUG	Ibuprofen 25 mg	Single administration
DRUG	Ibuprofen 15 mg	Single administration
DRUG	Strefen	Single administration

Timeline

• Start date: 2012-02-01
• Primary completion: 2012-11-01
• Completion: 2012-11-01
• First posted: 2012-02-17
• Last updated: 2012-11-12

Locations

4 sites across 3 countries: France, Germany, United Kingdom